VEGFA and age-related macular degeneration: Despite the current knowledge, many aspects of MLPED remain unexplored, such as its prevalence, occurrence of this phenomenon in non n-AMD neovascularization, underlying developmental factors other than anti-VEGF therapy, and so on.